Table 2.
Variable | OR | 95% CI | p-value |
---|---|---|---|
Age | 1.09 | 1.07–1.10 | <0.001 |
Largest tumor size | 0.77 | 0.69–0.85 | <0.001 |
Charlson Comorbidity Index | 1.66 | 1.5–1.84 | <0.001 |
Nephrometry Score | 1.85 | 1.37–2.5 | <0.001 |
(R)adius (1 vs. 3) | 5.2 | 1.78–15.2 | 0.003 |
(R)adius (2 vs. 3) | 3.27 | 1.15–9.26 | 0.026 |
(N)earness (1 vs. 3) | 2.3 | 1.5–3.6 | <0.001 |
(N)earness (2 vs. 3) | 2.5 | 1.5–4.2 | <0.001 |
(L)ocation (1 vs. 3) | 1.4 | 0.84–2.2 | <0.001 |
(L)ocation (2 vs. 3) | 1.3 | 0.8–2.1 | 0.274 |
Non-hilar | 2.7 | 1.2–5.8 | 0.015 |
Solitary Kidney | 1.4 | 0.6–3.4 | 0.394 |
Multifocal Tumor | 1.8 | 0.96–3.4 | 0.068 |
Controlling for gender, race, Eastern Cooperative Oncology Group Score, tumor laterality, endo/exophycity, anterior/posterior, and location relative to polar line.